News - Imagene AI

Newsroom

View our latest company news and media coverage to learn more about how we push the boundaries of precision medicine for cancer

Interview at Fortune Health 2022 - The Power Of AI: Revolutionizing And Democratizing Cancer Diagnosis

Press Releases

Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration with Sectra - ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Marketplace

12 February, 2024

Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling. Rapid NSCLC Biomarker Test already demonstrated its significant...

6 September, 2023

Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care. Leveraging AI-based molecular profiling from a biopsy image

15 August, 2023

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology, significantly improving patient outcomes

11 August, 2023

Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to its Scientific Advisory Board: Each Played a Historical Role in Advancing...

31 July, 2023

Imagene's AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

26 July, 2023

Imagene Wins Frost & Sullivan's Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis

2 May, 2023

Imagene Named 'Oncology Innovation of the Year' BioTech Breakthrough Awards that Recognizes Innovation in the...

3 November, 2022

New AI Tech Can Detect Cancerous Biomarkers in Real-Time Research Published in Modern Pathology journal

13 September, 2022

Imagene and Sourasky Medical Center to Present Collaborative Research: Image-based identification of HER2 status...

28 August, 2022

Imagene AI to Demonstrate Real-Time Biomarker Detection From H&E Images at ASCO 2022

1 June, 2022

Imagene AI CEO Dean Bitan to Speak at FORTUNE Brainstorm Health 2022

9 May 2022

Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer

2 May 2022

Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration with Sectra - ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Marketplace

12 February, 2024

Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling. Rapid NSCLC Biomarker Test already demonstrated its significant...

6 September, 2023

Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care. Leveraging AI-based molecular profiling from a biopsy image

15 August, 2023

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology, significantly improving patient outcomes

11 August, 2023

Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to its Scientific Advisory Board: Each Played a Historical Role in Advancing...

31 July, 2023

Imagene's AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

26 July, 2023

Imagene Wins Frost & Sullivan's Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis

2 May, 2023

Imagene Named 'Oncology Innovation of the Year' BioTech Breakthrough Awards that Recognizes Innovation in the...

3 November, 2022

New AI Tech Can Detect Cancerous Biomarkers in Real-Time Research Published in Modern Pathology journal

13 September, 2022

Imagene and Sourasky Medical Center to Present Collaborative Research: Image-based identification of HER2 status...

28 August, 2022

Imagene AI to Demonstrate Real-Time Biomarker Detection From H&E Images at ASCO 2022

1 June, 2022

Imagene AI CEO Dean Bitan to Speak at FORTUNE Brainstorm Health 2022

9 May 2022

Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer

2 May 2022

In The News

View the latest headlines featuring Imagene AI

English
Hebrew

StartUs Insights

Discover the Top 20 Promising Global Precision Medicine Startups

9 January, 2024

Market Watch

Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved manufacturing

1 June, 2023

Medgadget

Imagene Profiles Cancer Biomarkers in Real Time

22 March, 2023

Forbes

The Cancer Diagnosis Paradox

10 March, 2023

NoCamels

AI Cuts Cancer Wait From Weeks to Minutes

22 January, 2023

Galen Growth

250 most promising early-stage Digital Health ventures across the globe in 2022

14 December, 2022

The Epoch Times

New AI Technology Detects Cancer Mutations in Minutes

15 November, 2022

THE TIMES OF ISRAEL

Israeli hospital: New tech gave instant DNA info on tumors, jump-starts treatment

11 November, 2022

Jerusalem Post

Tel Aviv Sourasky Medical Center implements Israeli startup Imagene AI’s revolution

7 November, 2022

The Pathologist

Pathologists, We Need to Talk About Tech

3 October, 2022

Israel21c

Diagnosing cancer from biopsies in minutes, not weeks

20 September, 2022

The Jerusalem Post

New Israeli AI Tech Can Detect Cancerous Biomarkers in Real-time

15 September, 2022

Authority Magazine

Health Tech: Dean Bitan on How Imagene’s Technology Can Make an Important Impact on Our Overall Wellness

26 June, 2022

Tech Funding News

10 visionary startups in 2022 fighting cancer using AI

9 June, 2022

Medi Tech Insights

Digital Biomarkers Market

16 May, 2022

Fierce Biotech

Imagene nets $21.5M for cancer biopsy-scanning AI

6 May, 2022

Forbes

Imagene AI, which is developing machine learning to use biomarkers to detect cancer

4 May 2022

MobiHealthNews

Imagene AI raises $21.5 million across two rounds for precision cancer care

3 May 2022

Endpoints News

Wait, what? Oracle tech founder Larry Ellison invests into ex-stealth genomics diagnostics biotech

2 May, 2022

CTech

Larry Ellison leads $21.5 million Series A in cancer treatment startup Imagene AI

2 May, 2022

StartUs Insights

Discover the Top 20 Promising Global Precision Medicine Startups

9 January, 2024

Market Watch

Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved manufacturing

1 June, 2023

Medgadget

Imagene Profiles Cancer Biomarkers in Real Time

22 March, 2023

Forbes

The Cancer Diagnosis Paradox

10 March, 2023

NoCamels

AI Cuts Cancer Wait From Weeks to Minutes

22 January, 2023

Galen Growth

250 most promising early-stage Digital Health ventures across the globe in 2022

14 December, 2022

The Epoch Times

New AI Technology Detects Cancer Mutations in Minutes

15 November, 2022

THE TIMES OF ISRAEL

Israeli hospital: New tech gave instant DNA info on tumors, jump-starts treatment

11 November, 2022

Jerusalem Post

Tel Aviv Sourasky Medical Center implements Israeli startup Imagene AI’s revolution

7 November, 2022

The Pathologist

Pathologists, We Need to Talk About Tech

3 October, 2022

Israel21c

Diagnosing cancer from biopsies in minutes, not weeks

20 September, 2022

The Jerusalem Post

New Israeli AI Tech Can Detect Cancerous Biomarkers in Real-time

15 September, 2022

Authority Magazine

Health Tech: Dean Bitan on How Imagene’s Technology Can Make an Important Impact on Our Overall Wellness

26 June, 2022

Tech Funding News

10 visionary startups in 2022 fighting cancer using AI

9 June, 2022

Medi Tech Insights

Digital Biomarkers Market

16 May, 2022

Fierce Biotech

Imagene nets $21.5M for cancer biopsy-scanning AI

6 May, 2022

Forbes

Imagene AI, which is developing machine learning to use biomarkers to detect cancer

4 May 2022

MobiHealthNews

Imagene AI raises $21.5 million across two rounds for precision cancer care

3 May 2022

Endpoints News

Wait, what? Oracle tech founder Larry Ellison invests into ex-stealth genomics diagnostics biotech

2 May, 2022

CTech

Larry Ellison leads $21.5 million Series A in cancer treatment startup Imagene AI

2 May, 2022

In The News

View the latest headlines featuring Imagene AI

English
Hebrew

The Marker

ספר ההייטק הישראלי 2023

2 ינואר, 2023

ערוץ 13

פיתוח ישראלי: האלגוריתם שמוצא מוטציות סרטניות ומתאים תרופה (כתבת וידאו)

7 נובמבר, 2022

The Marker

20 הסטארטאפים המבטיחים של דה-מרקר ל 2022

2 באוגוסט, 2022

כלכליסט

לארי אליסון משקיע בחברת Imagene AI הישראלית

2 מאי, 2022

Ynet

סטארט-אפ ישראלי בסרטן: במקום לשלוח לביופסיה - אבחון במקום תוך 2 דקות

2 מאי, 2022

Tech12

איימג'ן AI גייסה 21 מיליון דולר מלארי אליסון כדי לזהות סרטן על בסיס ראיית מכונה

2 מאי, 2022

The Marker

לארי אליסון הוביל השקעה באימג'ין הישראלית, שרוצה להאיץ אבחון סרטן

2 מאי, 2022

גלובס

לארי אליסון שוב מהמר על הביומד הישראלי: חברת ImageneAI הודיעה על גיוס של 21.5 מיליון דולר

2 מאי, 2022

גלי צה"ל

מבט חדש על התא הסרטני: פיתוח ישראלי יקצר את זמן האבחון

2 מאי, 2022

Geektime

מה גורם למייסד אורקל, לארי אליסון, להשקיע ב Imagene AIהישראלית?

2 מאי, 2022

The Marker

ספר ההייטק הישראלי 2023

2 ינואר, 2023

ערוץ 13

פיתוח ישראלי: האלגוריתם שמוצא מוטציות סרטניות ומתאים תרופה (כתבת וידאו)

7 נובמבר, 2022

The Marker

20 הסטארטאפים המבטיחים של דה-מרקר ל 2022

2 באוגוסט, 2022

כלכליסט

לארי אליסון משקיע בחברת Imagene AI הישראלית

2 מאי, 2022

Ynet

סטארט-אפ ישראלי בסרטן: במקום לשלוח לביופסיה - אבחון במקום תוך 2 דקות

2 מאי, 2022

Tech12

איימג'ן AI גייסה 21 מיליון דולר מלארי אליסון כדי לזהות סרטן על בסיס ראיית מכונה

2 מאי, 2022

The Marker

לארי אליסון הוביל השקעה באימג'ין הישראלית, שרוצה להאיץ אבחון סרטן

2 מאי, 2022

גלובס

לארי אליסון שוב מהמר על הביומד הישראלי: חברת ImageneAI הודיעה על גיוס של 21.5 מיליון דולר

2 מאי, 2022

גלי צה"ל

מבט חדש על התא הסרטני: פיתוח ישראלי יקצר את זמן האבחון

2 מאי, 2022

Geektime

מה גורם למייסד אורקל, לארי אליסון, להשקיע ב Imagene AIהישראלית?

2 מאי, 2022

Contact Us

For media inquiries, please contact us at

media@imagene-ai.com

Cookie	Duration	Description
__hssrc	session	This cookie is set by Hubspot whenever it changes the session cookie. The __hssrc cookie set to 1 indicates that the user has restarted the browser, and if the cookie does not exist, it is assumed to be a new session.
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
__hssc	30 minutes	HubSpot sets this cookie to keep track of sessions and to determine if HubSpot should increment the session number and timestamps in the __hstc cookie.

Cookie	Duration	Description
__hstc	5 months 27 days	This is the main cookie set by Hubspot, for tracking visitors. It contains the domain, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
hubspotutk	5 months 27 days	HubSpot sets this cookie to keep track of the visitors to the website. This cookie is passed to HubSpot on form submission and used when deduplicating contacts.